TVRD
Tvardi Therapeutics
TVRD
TVRD
159 hedge funds and large institutions have $354M invested in Tvardi Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 56 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 164 → 159 (-5)
20% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 20
Holders
159
Holding in Top 10
1
Calls
$1.51M
Puts
$734K
Top Buyers
| 1 | +$6.56M | |
| 2 | +$2.59M | |
| 3 | +$1.62M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$740K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$709K |
Top Sellers
| 1 | -$4.57M | |
| 2 | -$3M | |
| 3 | -$2.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.21M |
| 5 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
-$1.6M |